ENDPOINTS

Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M

Plus, news about Kamari Pharma, Leyden Labs, Kiora, Senju, Alto Neuroscience, Chase Therapeutics, Nxera Pharma, Neurocrine Biosciences, Aytu BioPharma and Fabre-Kramer: On heels of pivotal readout, Vera Therapeutics refinances: The company, which

Jun 3, 2025 - 15:34
 0
Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M
Plus, news about Kamari Pharma, Leyden Labs, Kiora, Senju, Alto Neuroscience, Chase Therapeutics, Nxera Pharma, Neurocrine Biosciences, Aytu BioPharma and Fabre-Kramer: On heels of pivotal readout, Vera Therapeutics refinances: The company, which
Read More

Tags:

Previous Article

The surprising power of photography in aging well

Next Article

How likely is life on Mars?

Related Posts

Roche could rethink $50B US expansion plan if new policies 'harm' operations

Roche could rethink $50B US expansion plan if new polic...

May 12, 2025  0

China is closing in on US biotech, Harvard report warns

China is closing in on US biotech, Harvard report warns

Jun 5, 2025  0

GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars

GSK, Spero report Phase 3 win for UTI antibiotic; Spero...

May 28, 2025  0